NCT04862546 is a NA clinical trial of Laser Acupoint in Hyperhidrosis, sponsored by Kafrelsheikh University.

Who is sponsoring NCT04862546?

NCT04862546 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT04862546?

Interventions in NCT04862546: Laser Acupoint, Tap water iontophoresis.

What condition does NCT04862546 study?

NCT04862546 studies Hyperhidrosis.

Is NCT04862546 still recruiting?

NCT04862546 is currently completed. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT04862546

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis

Completed NA Last updated 16 September 2021

What this trial tests

NA trial testing Laser Acupoint in Hyperhidrosis in 40 participants. Completed in 7 September 2021.

Timeline

1 February 2021

Primary endpoint
9 July 2021

7 September 2021

Quick facts

Lead sponsor	Kafrelsheikh University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	1 February 2021
Primary completion	9 July 2021
Estimated completion	7 September 2021
Sites	1 location across Egypt

Drugs / interventions tested

Laser Acupoint
Tap water iontophoresis

Conditions studied

Hyperhidrosis — all drugs for Hyperhidrosis →

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 22, any sex, with Hyperhidrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the purpose of the present study is to assess the effect of laser acupoints on subjects with hyperhidrosis in comparison to tap water iontophoresis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hyperhidrosis

Currently open trials in the same condition.

NCT05805696 — Treatment and Mapping of Impostor Phenomenon · NA · recruiting
NCT05102396 — Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? · Phase 2 · recruiting
NCT05403710 — Botulinum Toxin Therapy in Hidradenitis Suppurativa · recruiting

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04862546 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04862546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing